Ex-Pfizer Worker Seeks No Time For Paxlovid Insider Trading

By Emilie Ruscoe · July 15, 2024, 10:51 PM EDT

A former Pfizer employee argued that he shouldn't go to prison after a Manhattan federal jury convicted him of insider trading over clinical trial results for the drug Paxlovid, pointing out...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

Case Number

Court

New York Southern

Nature of Suit

Date Filed

June 28, 2023

Recent Articles By Emilie

May 20, 2024
Teladoc Faces Suit Over Mental Health Platform's Losses
May 14, 2024
Vein Tech Maker Faces Investor Suit Over DOJ Kickback Probe
April 19, 2024
AI Health Data Co. Faces Investor Suit Over Accounting Issues
April 18, 2024
Doximity Faces Investor Suit Over Slashed Revenue Hopes
March 15, 2024
'Cobra Venom' Painkiller Co. Inks Deal To Settle SEC Claims
February 21, 2024
Former Exec Convicted Of Medtronic Insider Trading Scheme
February 12, 2024
Investors Win Class Cert. Against Failed COVID Test Maker
January 22, 2024
Investors Sue Biopharma Co. After Clinical Trial Data Toss
December 19, 2023
Acadia Investor Says Officers Overhyped Drug's Prospects
December 06, 2023
Cancer Test Co. Overpromised Insurer Coverage, Suit Says